GDF15 and neoplasm: We have previously demonstrated that growth differentiation factor 15 (GDF15) can change the tumor immune microenvironment and promote the occurrence and development of HCC, making it an important target for hepatocellular carcinoma immunotherapy.[7] The expression of GDF15 is typically low in normal tissues and does not significantly affect normal cells.